Terms: = Breast cancer AND CSF3R, CD114, 1441, ENSG00000119535, GCSFR AND Prognosis
5 results:
1. HiFreSP: A novel high-frequency sub-pathway mining approach to identify robust prognostic gene signatures.
Li M; Zhao J; Li X; Chen Y; Feng C; Qian F; Liu Y; Zhang J; He J; Ai B; Ning Z; Liu W; Bai X; Han X; Wu Z; Xu X; Tang Z; Pan Q; Xu L; Li C; Wang Q; Li E
Brief Bioinform; 2020 Jul; 21(4):1411-1424. PubMed ID: 31350847
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative breast cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract] [Full Text] [Related]
3. The prognostic significance of Cdc6 and Cdt1 in breast cancer.
Mahadevappa R; Neves H; Yuen SM; Bai Y; McCrudden CM; Yuen HF; Wen Q; Zhang SD; Kwok HF
Sci Rep; 2017 Apr; 7(1):985. PubMed ID: 28428557
[TBL] [Abstract] [Full Text] [Related]
4. Nestin: predicting specific survival factors for breast cancer.
Gao N; Xu H; Liu C; Xu H; Chen G; Wang X; Li Y; Wang Y
Tumour Biol; 2014 Mar; 35(3):1751-5. PubMed ID: 24443256
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors.
Axelson H; Fredlund E; Ovenberger M; Landberg G; PĂ„hlman S
Semin Cell Dev Biol; 2005; 16(4-5):554-63. PubMed ID: 16144692
[TBL] [Abstract] [Full Text] [Related]